With Stake, Australia's leading investing platform, I'm excited to share the sixth episode of 'Going Public' - a new monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.

This month's episode features Dr Alan Taylor the Executive Chairman of Clarity Pharmaceuticals which is a clinical-stage cancer biotech company based in Australia. The company specialises in developing radiopharmaceutical products that can be used to image and diagnose various types of cancer.

Clarity Pharmaceuticals is actively involved in extensive research, development, and clinical stage evaluation of its portfolio of novel radiopharmaceutical products.

The company was listed on the ASX in 2021 under the ticker CU6.

DISCLAIMER:

Views expressed are those of the individual only. This does not constitute financial advice.